Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
Midwest Regional Forum June 2017
Share |
 
Thursday, June 8, 2017

University Center of Lake County
1200 University Center Drive
Grayslake, IL 60030
 
Online Registration is now CLOSED.
There will be NO ONSITE REGISTRATION available for this program.





Challenges or Special Considerations When Developing ADCs and Bispecifics


 

The CASSS Midwest Regional Forum is committed to bringing job-relevant educational and regulatory trends  for biopharmaceuticals to CASSS members through meeting programs. The June program will focus on understanding Antibody Drug Conjugates (ADCs) and Bispecific Antibodies and the unique challenges these molecules present during product development. The discussion will include content from other regional, national or international forums organized by CASSS and speakers from both industry and the FDA. The program will also provide a platform for networking with peers and regulatory authorities.

 

 Learning Objectives: 

1. Discuss current CMC development FDA challenges, trends and expectations for ADCs and Bispecifics with industry               and FDA colleagues.

2. Learn industry best practices in overcoming development challenges for ADCs and Bispecific mAbs.
    Key areas of focus will include: 

     a. Process development experiences and challenges in the conjugation chemistry for ADCs. 
     b. Formulation, stability, and analytical method / characterization challenges with ADCs.
     c. Process development experiences and challenges in the development of Bispecifics mAbs.
     d. Control strategy considerations for Bispecific mAbs and ADCs. 

 

Want more information? Check out the "More in this Section" dropdown box at the top of the page!
Or contact CASSS at 510-428-0740 or info@casss.org

 


  

 

 

 
 
 
Membership Software Powered by YourMembership  ::  Legal